1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Anthony Caputa, Ph.D. Technology Center Practice Specialist 571-272-0829 TC 1600.

Slides:



Advertisements
Similar presentations
Enhanced First Action Interview (EFAI) Pilot Program
Advertisements

The Examination Process
First Action Interview Pilot Program Overview. Pilot Program Objectives Promote personal interviews prior to issuance of a first Office action on the.
Accelerating Patent Prosecution Thursday, October 18, 2012.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting October 8, 2002 William F. Smith Administrative Patent Judge Board of Patent Appeals.
Julie Burke TC1600 QAS REJOINDER PRACTICE Julie Burke TC1600 QAS
1 1 AIPLA American Intellectual Property Law Association RCE Practice: Pilot Programs and Delays in Examination Chris Fildes Fildes & Outland, P.C. IP.
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Appeal Practice Before Board of Patent Appeals and Interferences
Enhanced First Action Interview (EFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
TC1600 Appeals Practice Jean Witz, Appeals Specialist.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Modifications to the USPTO Count System Sponsored by the Chartered Institute of Patent.
July 8, Enhanced Examination Timing Control Robert A. Clarke Deputy Director Office of Patent Legal Administration
Accelerated Examination Bennett Celsa (TC 1600: QAS)
Patent Term Adjustment (Bio/Chem. Partnership) Kery Fries, Sr. Legal Advisor Phone: (571)
Green Technology Petition Pilot Robert W. Bahr. 2 Green Tech: Discussion Points 1. Authority and Overview: resources / overview 2.Petition Requirement:
JPAA International Activities Center Nobuo Sekine
Appeal Practice Refresher Office of Patent Training.
Full First Action Interview (FFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
IDS And Amendments Filed After Final Rejection Presented By:Steven P. Scuderi Pepe & Hazard LLP Pepe & Hazard LLP.
The New USPTO Rules and their Impact on Biomedical Patent Prosecution Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer.
2 23,503 hours in FY 2013, compared with 21,273 hours in FY ,651 interview hours in FY 13 have been charged through the AFCP program. Interview.
Accelerated Examination Program Andrew Faile Director, TC 2600.
1 1 Interview Practice Within the USPTO. 2 2 Topics Effective Interviews Reaching Agreement Requesting Interviews Issues Discussed Documenting Interviews.
Best Practices for Graduate Supervision December 10, 2014 Your Role in Graduate Studies.
1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)
November 29, Global Intellectual Property Academy Advanced Patents Program Kery Fries, Senior Legal Advisor Mark Polutta, Senior Legal Advisor Office.
1 LAW DIVISION PATENT DIVISION TRADEMARK & DESIGN DIVISION ACCOUNTING & AUDITING DIVISION YUASA AND HARA LAW, PATENT, TRADEMARK & DESIGN and ACCOUNTING.
1 Biotechnology/Chemical/Pharmaceutical Customer Partnership June 1, 2010 Valencia Martin-Wallace – Director, Technology Center 2400.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Election of Species Joseph K. McKane SPE, Art Unit 1626 April 27, 2004.
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Patent.
Yoshiki KITANO JPAA International Activities Center AIPLA Annual Meeting, 2014 IP Practice in Japan Committee Pre-Meeting Seminar Post-Grant Opposition.
1 Rules of Practice Before the BPAI in Ex Parte Appeals 73 Fed. Reg (June 10, 2008) Effective December 10, Fed. Reg (June 10, 2008)
Biotech Customer Partnership August 3, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)
1 When is it NOT Appropriate to Restrict? Julie Burke TC1600 QAS
After Final Practice Linda M. Saltiel June 2, 2015.
Reexamination at the USPTO Robert A. Clarke Deputy Director Office of Patent Legal Administration USPTO Robert A. Clarke Deputy Director Office of Patent.
Compact Prosecution Bennett Celsa TC Quality Assurance Specialist (December 2009)
Scholarly Publication: Responsibilities for Authors and Reviewers Jean H. Shin, Ph.D. Director, Minority Affairs Program American Sociological Association.
Leon Radomsky The Marbury Law Group PLLC Interview Practice and Knowing the USPTO.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
3 rd Party Participation Bennett Celsa TC 1600 QAS.
QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.
FY09 Restriction Petition Update; Comparison of US and National Stage Restriction Practice Julie Burke TC1600 Quality Assurance Specialist
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
Claims Proposed Rulemaking Main Purposes É Applicant Assistance to Improve Focus of Examination n Narrow scope of initial examination so the examiner is.
101 Issues in the US Middleton Reutlinger MIDDLETON REUTLINGER
Prosecution Group Luncheon Patent October PTO News Backlog of applications continues to decrease –623,000 now, decreasing about 5,000/ month –Expected.
Claims and Determining Scope of Protection -Introduction Nov. 9, 2014 APAA Patents Committee Penang Malaysia Kay Konishi Co-chair of APAA Patents Committee.
Andrew B. Freistein Wenderoth, Lind & Ponack, L.L.P. Learning the ABC’s of Patent Term Adjustment 1 © AIPLA 2015.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
The Role of a Program Director NCI Division of Cancer Biology New Grantee Workshop October 18-19, 2010 Jerry Li, MD, PhD Division of Cancer Biology NCI/NIH.
Report to the AIPLA’s IP Practice in Japan Committee January 22, 2012 USPTO Appeal Process: Appeal Strategies and New Rules Presented by: Stephen S. Wentsler.
Equal Employment Opportunity (EEO) Division of Immigration Health Services FY 2010.
1. Video Conference Interviews 2 Sean Hagan Director of the Midwest Regional United States Patent and Trademark Office Webinar for Knobbe Martens January.
Sudhanshu C. Pathak Resource Supervisor Denver Satellite Office USPTO United States Patent and Trademark Office Examiner Interview Practice NAPP Annual.
Complying with HEFCE open access requirement for eligibility to REF2021 submission How to create a record in Pure and upload your ‘Author’s Accepted Manuscript’
Accelerated Patent Examination: Green Technology A Summary of Global Initiatives, with specific discussion of the US Speaker: Matt Prater Preparation help.
1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600.
Prosecution Luncheon Patent July 2016
Preparing a Patent Application
Pre-Issuance (Third-Party) Submissions
USPTO Appeal Process: Appeal Strategies and New Rules
PTAB Litigation 2016 Part 8 – Oral Hearing
Biotech/Chem/Pharm Customer Partnership Meeting, March 15, 2005
Preparing a Patent Application
First Action Interview Pilot Program
Boston Patent Law Association Annual Meeting
Presentation transcript:

1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Anthony Caputa, Ph.D. Technology Center Practice Specialist TC 1600

2 How Applicant can use the TPS or QAS Applicant can use TCPS or QAS to discuss patentability issues in applications which are not being resolved by the SPE or examiner Applicant can use TCPS or QAS to discuss TC policy issues (restriction, written description) Applicant can use TCPS or QAS to determine who to contact on various issues

3 TIPS ON EFFECTIVE INTERVIEW Interview should be held only when the nature of the case is such that the interview could serve to develop and clarify specific issues Interview should be arranged in advance An interview should not extend beyond a reasonable period, usually no longer than 30 minutes Submit an Applicant Initiated Interview Request Form (PTOL-413A) prior to an interview

4

5 Tips on a Effective Interview Substance of interview must be of record Applicant is responsible for making the substance of an interview of record except when the interview is initiated by the examiner and the examiner provides a written summary Interview Summary form does not need to be completed with an examiner’s amendment

6

7 When interviews are prohibited or granted. Interviews are not permitted prior to filing. However, Examiner may indicate the field of search. See MPEP Interview prior to first Office action is ordinarily granted in continuing applications in TC In other applications a request before the first office action will not be granted or acknowledged in TC 1600.

8 When interviews are prohibited or granted. Interviews are not permitted after an appeal brief is filed or after an application has been passed to issue except in unusual situations Normally one interview after final rejection is permitted. A further interview may be held if it will expedite the issues on appeal or dispose of the application

9 After Final Practice Once a final rejection has been entered in an application, Applicant no longer has the right to unrestricted further prosecution ( i.e. to amend or add new claims) The prosecution of an application before the examiner should ordinarily be concluded with the final Office action Difficulties encountered with prosecution after final may be alleviated by including claims varying in scope from the broadest to the most narrowest which Applicant is willing to accept

10 After Final Practice A reply to a final rejection is limited to: oAn Amendment/Argument in compliance with 37 CFR oNotice of Appeal oProper RCE oWhen applicant files an RCE, it is suggested that the applicant clearly indicate whether or not any previously filed after-final amendment should be entered

11 Questions Anthony Caputa uspto.gov